Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 14-Mar-2022 titled Alembic Pharmaceuticals receives USFDA Tentative Approval for Macitentan Tablets, 10 mg.
Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 14-Mar-2022 titled Alembic Pharmaceuticals receives USFDA Tentative Approval for Macitentan Tablets, 10 mg.